Impact of timing of pregnancy and genetic risk on local therapy choices for young women with breast cancer

By sjmartinez • November 6, 2024

Lipsyc-Sharf M, Huang M, Huang SY, Suresh YK, Doll A, Baker JL, Kapoor NS. Impact of timing of pregnancy and genetic risk on local therapy choices for young women with breast cancer. Am J Surg. 2024 Oct 29;239:116060. doi: 10.1016/j.amjsurg.2024.116060. Epub ahead of print. PMID: 39500008.

Tags: Hematology/Oncology, Publications

Related Posts

Phase Ib/II trial of anti-CD33 monoclonal antibody BI 836858 and azacitidine in previously untreated older acute myeloid leukemia patients: Beat AML S2 sub-study results

Hochman MJ, Ruppert AS, Huang Y, Mims A, Borate U, Swords R, Traer E, Baer MR, Duong VH, Stock W, Odenike T, Patel P, Madanat[...]

Phase II randomised study of magrolimab combined with bevacizumab-FOLFIRI in patients with previously treated advanced inoperable metastatic colorectal cancer

Fakih M, Gill S, Sampat K, Chan DL, Fisher G, Cruz-Correa M, Lenz HJ, Garcia-Alfonso P, Forget F, Lonardi S, Krauss J, Chen E, Cubillo[...]

Clinical Outcomes of Lentiviral Vector Gene Therapy for Sickle Cell Disease

Prueksapraopong C, Fernandes A, Campo Fernandez B, Roy S, Hollis RP, Habtemariam B, Pellin D, Ceoldo G, Lin TY, Dang TT, Cornetta K, Romero Z,[...]